|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/85 |
| (11) | Patento numeris | 2870250 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13813225.3 |
| Europos patento paraiškos padavimo data | 2013-07-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-05-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/049460 |
| Data | 2013-07-05 |
| (87) | Numeris | WO 2014/008480 |
| Data | 2014-01-09 |
| (30) | Numeris | Data | Šalis |
| 201261668889 P | 2012-07-06 | US |
| (72) |
LOW, Susan, US
DUMONT, Jennifer A., US
BITONTI, Alan J., US
|
| (73) |
Bioverativ Therapeutics Inc.,
225 Second Avenue, Waltham, MA 02451,
US
|
| (54) | CELL LINE EXPRESSING SINGLE CHAIN FACTOR VIII POLYPEPTIDES AND USES THEREOF |
| CELL LINE EXPRESSING SINGLE CHAIN FACTOR VIII POLYPEPTIDES AND USES THEREOF |